Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

C Hu, J Yang, Z Qi, H Wu, B Wang, F Zou, H Mei… - MedComm, 2022 - Wiley Online Library
The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …

HSP90 inhibitors and cancer: Prospects for use in targeted therapies

ZN Li, Y Luo - Oncology reports, 2022 - spandidos-publications.com
Heat shock protein 90 (HSP90) is a vital chaperone protein, regulating signaling pathways
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …

Targeting heat shock proteins in cancer: a promising therapeutic approach

S Chatterjee, TF Burns - International journal of molecular sciences, 2017 - mdpi.com
Heat shock proteins (HSPs) are a large family of chaperones that are involved in protein
folding and maturation of a variety of “client” proteins protecting them from degradation …

[Retracted] Apoptosis and Molecular Targeting Therapy in Cancer

M Hassan, H Watari, A AbuAlmaaty… - BioMed research …, 2014 - Wiley Online Library
Apoptosis is the programmed cell death which maintains the healthy survival/death balance
in metazoan cells. Defect in apoptosis can cause cancer or autoimmunity, while enhanced …

Biophysics in drug discovery: impact, challenges and opportunities

JP Renaud, C Chung, UH Danielson, U Egner… - Nature reviews Drug …, 2016 - nature.com
Over the past 25 years, biophysical technologies such as X-ray crystallography, nuclear
magnetic resonance spectroscopy, surface plasmon resonance spectroscopy and …

[HTML][HTML] Discovery of small molecule cancer drugs: successes, challenges and opportunities

S Hoelder, PA Clarke, P Workman - Molecular oncology, 2012 - Elsevier
The discovery and development of small molecule cancer drugs has been revolutionised
over the last decade. Most notably, we have moved from a one-size-fits-all approach that …

Old and new approaches to target the Hsp90 chaperone

J Sanchez, TR Carter, MS Cohen… - Current cancer drug …, 2020 - ingentaconnect.com
The 90-kDa heat shock protein (Hsp90) is a molecular chaperone that ensures cellular
proteostasis by maintaining the folding, stabilization, activation, and degradation of over 400 …

Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions

L Li, L Wang, QD You, XL Xu - Journal of medicinal chemistry, 2019 - ACS Publications
Hsp90 is one of the most important chaperones involved in regulating the maturation of
more than 300 client proteins, many of which are closely associated with refractory diseases …

Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-Methylpropargylamine-conjugated 4 …

HJ Tseng, S Banerjee, B Qian, MJ Lai, TY Wu… - European Journal of …, 2023 - Elsevier
Abstract Monoamine oxidase A (MAO A) and heat shock protein 90 (HSP90) inhibitors have
been shown to decrease the progression of glioblastoma (GBM) and other cancers. In this …

POVME 3.0: software for mapping binding pocket flexibility

JR Wagner, J Sørensen, N Hensley… - Journal of chemical …, 2017 - ACS Publications
We present a substantial update to the open-source POVME binding pocket analysis
software. New capabilities of POVME 3.0 include a flexible chemical coloring scheme for …